Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Biol Chem. Nov 26, 2015; 6(4): 333-345
Published online Nov 26, 2015. doi: 10.4331/wjbc.v6.i4.333
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
Shafqat Ali Khan, Divya Reddy, Sanjay Gupta
Shafqat Ali Khan, Divya Reddy, Sanjay Gupta, Epigenetics and Chromatin Biology Group, Gupta Laboratory, Cancer Research Centre, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai 410210, India
Author contributions: Khan SA and Gupta S contributed to the conception, design and major portion of the manuscript writing; Reddy D contributed in manuscript writing and editing.
Conflict-of-interest statement: No potential conflicts of interest relevant to this article were reported.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Sanjay Gupta, PhD, Principal Investigator, Epigenetics and Chromatin Biology Group, Gupta Laboratory, Cancer Research Centre, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Sector 22, Navi Mumbai 410210, India. sgupta@actrec.gov.in
Telephone: +91-022-27405086
Received: June 1, 2015
Peer-review started: June 2, 2015
First decision: June 18, 2015
Revised: September 21, 2015
Accepted: October 1, 2015
Article in press: October 8, 2015
Published online: November 26, 2015
Processing time: 174 Days and 17.4 Hours
Core Tip

Core tip: The purpose of the review is to describe the potential of histone post-translational modifications in the field of cancer.